Anzeige
Mehr »
Mittwoch, 17.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JQ1X | ISIN: CA0717341071 | Ticker-Symbol: BVF
Tradegate
17.09.25 | 13:21
5,747 Euro
+0,74 % +0,042
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
BAUSCH HEALTH COMPANIES INC Chart 1 Jahr
5-Tage-Chart
BAUSCH HEALTH COMPANIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,7185,75314:16
5,7165,75514:00

Aktuelle News zur BAUSCH HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrBausch Health Companies Inc: Bausch Health completes tender offer to acquire Durect2
FrBausch Health Completes $63 Mln Acquisition Of DURECT, Adds Breakthrough AH Therapy3
DoBausch Health Companies Acquires Durect Corporation2
DoBausch Health Companies Inc. - 8-K, Current Report1
DoBausch Health Companies Inc.: Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio391The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development, to Bausch Health's hepatology pipeline LAVAL...
► Artikel lesen
05.09.Bausch Health Companies Inc.: Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage Non-Surgical System236LAVAL, QC / ACCESS Newswire / September 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta Medical, a global leader in the medical aesthetics...
► Artikel lesen
05.09.Bausch Health's Thermage technology surpasses 5 million treatments6
26.08.Bausch Health Companies Inc: Bausch Health extends Durect tender offer to Sept. 104
BAUSCH HEALTH Aktie jetzt für 0€ handeln
26.08.Bausch Health Companies Inc.: Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025274LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ:DRRX)...
► Artikel lesen
21.08.Bausch Health Companies Inc: Bausch's Cabtreo acne drug on two provincial drug plans3
21.08.Bausch Health Companies Inc.: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, CABTREO, Now Available Through Public Drug Plans of Quebec and Saskatchewan291LAVAL, QC / ACCESS Newswire / August 21, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced that...
► Artikel lesen
21.08.Bausch Health: Umsatzwachstum in Q2 2025, Aktie bricht trotz Gewinnüberraschung ein 18
20.08.A Look Into Bausch Health Companies Inc's Price Over Earnings2
18.08.Bausch Health (BHC) Climbs 45% on Insider Buying2
15.08.Bausch Health stock soars after Paulson increases stake3
15.08.Paulson erhöht Anteil: Aktie von Bausch Health legt kräftig zu27
15.08.Bausch Health Companies Inc. - 8-K, Current Report2
15.08.Paulson Capital increases stake in Bausch Health to 19.13%2
15.08.Paulson Capital übernimmt Icahn-Anteil an Bausch Health und hält nun 19,13 %11
15.08.Bausch Health Companies Inc.: Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes442LAVAL, QC / ACCESS Newswire / August 15, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced that Paulson Capital Inc. and certain affiliates and...
► Artikel lesen
Weiter >>
139 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,12